Genus plc (LON:GNS - Get Free Report) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 2,204 ($29.96) and last traded at GBX 2,200.48 ($29.91), with a volume of 201718 shares changing hands. The stock had previously closed at GBX 2,130 ($28.96).
Analyst Upgrades and Downgrades
Separately, Shore Capital restated a "buy" rating on shares of Genus in a report on Wednesday, April 30th.
View Our Latest Research Report on GNS
Genus Stock Up 3.6%
The firm has a market cap of £1.44 billion, a price-to-earnings ratio of 182.85, a PEG ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The business's 50 day moving average price is GBX 2,021.58 and its 200 day moving average price is GBX 1,841.10.
Genus Company Profile
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
